GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of VVY.AS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Friday for Vivoryon Therapeutics N.V. stock after losing 3.62%
(Updated on Apr 19, 2024)

Sell candidate since Apr 04, 2024 Loss -13.22% PDF

The Vivoryon Therapeutics N.V. stock price fell by -3.62% on the last day (Friday, 19th Apr 2024) from 0.470€ to 0.453€. During the last trading day the stock fluctuated 6.59% from a day low at 0.440€ to a day high of 0.469€. The price has fallen in 8 of the last 10 days and is down by -14.2% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -184 thousand shares and in total, 100 thousand shares were bought and sold for approximately 45.19€ thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Due to the high volatility and the trend direction we are not able to give forecast range for this stock. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

VVY.AS Signals & Forecast

There are mixed signals in the stock today. The Vivoryon Therapeutics N.V. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at 0.471€ and 1.00€. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Wednesday, April 17, 2024, and so far it has risen 7.47%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Vivoryon Therapeutics N.V. stock

On the downside, the stock finds support just below today's level from accumulated volume at 0.422€. With no support from accumulated volume below today's level the risk is increased, as a drop below the support at € may give a huge drop in the stock price.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved 0.0290€ between high and low, or 6.59%. For the last week the stock has had daily average volatility of 9.25%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (VVY.AS) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Vivoryon Therapeutics N.V. to open at 0.454€, and during the day (based on 14 day Average True Range), to move between 0.331€ and 0.575€, which gives a possible trading interval of +/-0.122€ (+/-26.97%) up or down from last closing price. If Vivoryon Therapeutics N.V. takes out the full calculated possible swing range there will be an estimated 53.93% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at 0.422€ (6.95%) than the resistance at 0.511€ (12.80%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Vivoryon Therapeutics N.V. stock A Buy?

Vivoryon Therapeutics N.V. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -3.581 Sell Candidate Unchanged

Predicted Opening Price for Vivoryon Therapeutics N.V. of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
0.454€ ( 0.221%) 0.453€

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for VVY.AS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.483 6.62 %
R2 0.472 4.18 %
R1 0.465 2.67 %
Current price: 0.453
Support S1 0.443 -2.22 %
S2 0.436 -3.74 %
S3 0.425 -6.18 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.559 23.40 %
R2 0.554 22.30 %
R1 0.511 12.80 %
Current price 0.453
Support S1 0.422 -6.95%
S2 0 .
S3 0 .

FAQ

What is the symbol for Vivoryon Therapeutics N.V. Stock and on which exchange is it traded?
The symbol for Vivoryon Therapeutics N.V. is VVY.AS and it is traded on the AMS (Euronext Amsterdam).

Should I buy or sell Vivoryon Therapeutics N.V. Stock?
Vivoryon Therapeutics N.V. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Vivoryon Therapeutics N.V. Stock?
Vivoryon Therapeutics N.V. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Vivoryon Therapeutics N.V. Stock.

What's the current price of Vivoryon Therapeutics N.V. Stock?
As of the end of day on the 2024-04-19, the price of an Vivoryon Therapeutics N.V. (VVY.AS) share was 0.453€.

What is the 52-week high and low for Vivoryon Therapeutics N.V. Stock?
The 52-week high for Vivoryon Therapeutics N.V. Stock is 19.56€ and the 52-week low is 0.410€.

What is the market capitalization of Vivoryon Therapeutics N.V. Stock?
As of the 2024-04-19, the market capitalization of Vivoryon Therapeutics N.V. is 12.169M.
Click to get the best stock tips daily for free!

About Vivoryon Therapeutics N.V.

Vivoryon Therapeutics N.V. Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research and development of therapeutic products for the treatment of Alzheimer's disease. Its pipeline products target toxic pyroglutamate-Abeta (pGlu-Abeta), which inhibits the production of pGlu-Abeta. The company's lead product candidate is PQ912, a small molecule QC inhibitor that has completed Phase IIb clinical trials for use in the treatment of Alzheime... VVY.AS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT